Silva Pharmaceuticals Limited (DSE:SILVAPHL)
Bangladesh · Delayed Price · Currency is BDT 16.20
-0.20 (-1.22%)
At close: Aug 13, 2026
Silva Pharmaceuticals Market Cap
Silva Pharmaceuticals has a market cap or net worth of 2.21 billion as of August 14, 2026. Its market cap has increased by 37.29% in one year.
Market Cap
2.21B
Enterprise Value
2.13B
Revenue
329.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.20
ChartMarket Cap Chart
Since October 10, 2018, Silva Pharmaceuticals's market cap has decreased from 3.77B to 2.21B, a decrease of -41.34%. That is a compound annual growth rate of -6.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 2.21B | 72.34% |
| Dec 30, 2025 | 1.28B | -7.84% |
| Dec 30, 2024 | 1.39B | -52.78% |
| Dec 28, 2023 | 2.95B | - |
| Dec 29, 2022 | 2.95B | 20.67% |
| Dec 30, 2021 | 2.44B | -2.19% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| The IBN SINA Pharmaceutical Industry | 10.07B |
| Navana Pharmaceuticals | 7.45B |
| Orion Pharma | 6.69B |
| Techno Drugs | 5.98B |
| Indo-Bangla Pharmaceuticals | 2.24B |
| Silco Pharmaceuticals | 2.10B |
| Pharma Aids | 1.95B |
| Ambee Pharmaceuticals | 1.93B |